AKT1 and gastric cancer: Consistent with the downstream mechanism of CXCR7/β-arrestin2 axis in gastric cancer [23], the decrease in β-arrestin2 led to reduced AKT phosphorylation compared to the nonsense control (Figure 6(f-i)).